Patients like Isabelle are the reason why Charles River is dedicated to serving the medical device industry with robust preclinical testing programs and therapeutic area expertise. Our state-of-the-art Boisbriand facility was proud to support the development of Isabelle’s TAVI device. Simultaneously serving patients at CHUM, Dr. Leclerc leads our Boisbriand team as the site’s Senior Director of Medical Devices and was part of the core team that worked on Isabelle’s device. He is energized by the capabilities our organization can contribute to the advances of medical device therapy. “With today’s nanotechnologies, 3D printing, artificial intelligence, we can now find solutions to diseases that could not be solved 5, 10 years ago.”
As a collaborator on the TAVI, fellow interventional cardiologist Dr. Potvin attests to the value that an organization like Charles River brings to the medical device development process. “By working in a rigorous environment like Charles River, the whole facility is so well-established and so well equipped, we could develop a model that eventually became the benchmark in the industry,” he says.